Serum FGF21 levels in adult m.3243A>G carriers: Clinical implications.

MLA

Koene, Saskia, et al. “Serum FGF21 Levels in Adult m.3243A>G Carriers: Clinical Implications.” Neurology, vol. 83, no. 2, July 2014, pp. 125–33. EBSCOhost, https://doi.org/10.1212/WNL.0000000000000578.

APA

Koene, S., de Laat, P., van Tienoven, D. H., Vriens, D., Brandt, A. M., Sweep, F. C. G. J., Rodenburg, R. J. T., Donders, A. R. T., Janssen, M. C. H., & Smeitink, J. A. M. (2014). Serum FGF21 levels in adult m.3243A>G carriers: Clinical implications. Neurology, 83(2), 125–133. https://doi.org/10.1212/WNL.0000000000000578

Chicago

Koene, Saskia, Paul de Laat, Doorlène H van Tienoven, Dennis Vriens, André M Brandt, Fred C G J Sweep, Richard J T Rodenburg, A Rogier T Donders, Mirian C H Janssen, and Jan A M Smeitink. 2014. “Serum FGF21 Levels in Adult m.3243A>G Carriers: Clinical Implications.” Neurology 83 (2): 125–33. doi:10.1212/WNL.0000000000000578.